The overall programme was aimed at understanding and delving deeper into what is coming in the space of automation and utilisation of big data in the future
Drug Information Association (DIA) India recently organised a conference on Innovations in Clinical Data Management and Biostatistics in Bengaluru on the theme ‘The Era of Big Data’. The single-day conference discussed and explored the latest trends and developments in the space of clinical data management and biostatistics, and the impact of innovations such as artificial intelligence, machine learning, process automation and real world evidence on driving better clinical trial outcomes.
While Mayank Anand, Head, Global Data Management Service Delivery, Global Data Management and Centralized Monitoring, Bristol Myers Squibb, served as Programme Chair, Dr Deepak Kallubundi, Associate Director, Clinical Analytics and Clinical Data Management, Covance served as Program CoChair. The programme committee, consisting of senior industry executives from the Indian healthcare fraternity, was successful in driving an insightful discussion on the way forward for the clinical trial industry and future data management and biostatistics professionals
The conference witnessed three individual sessions and a break out session for data management and biostatistics, over 10 presentations, four case sharing sessions and two grand panel discussions. Over 30 national and international subject matter experts from the industry participated in the discussions, as did global decisionmakers and influencers from the pharmaceutical, biotechnology, services and academic communities.
This story is from the June 16-30, 2019 edition of Express Pharma.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the June 16-30, 2019 edition of Express Pharma.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
Powerful Process Control with IND500x Weighing Indicators
Ensuring consistent quality in hazardous environments, particularly in Ex-Areas (Zone 1/21, Division 1), is a critical aspect of industrial operations. The IND500x weighing indicators from METTLER TOLEDO provide a robust solution for these challenging settings, offering optimized safety and productivity.
Ensuring clean room integrity with prime clean reset high-speed doors
Prime Clean Reset high-speed doors ensure airtight seals, minimising air permeability and contamination in clean rooms. Designed for sensitive environments, they enhance operational efficiency and meet rigorous regulatory standards, making them ideal for pharmaceutical and biotech industries
Complete environmental monitoring solution - testo Saveris Pharma
There are several critical applications in the industry like research and development that demand for continuous & reliable monitoring of important environmental parameters.
Adaptive Manufacturing:-The new flexibility in medical device assembly
Unlike traditional, rigid production lines, B&R's adaptive machines seamlessly adjust to the requirements of each device, dynamically adapting to each unique process
Reshaping pharma safety with active packaging innovations
CILICANT is revolutionising active packaging with solutions tailored for the most sensitive formulations. Meet the innovators driving stability, safety, and impurity control in pharma packaging at CPhI India
UNLOCKING GROWTH FRONTIERS
Vadodara Pharma Summit 2024 brought together industry leaders and experts to highlight the city's pivotal role in India's pharma landscape and explore collaborative strategies to strengthen India's pharma innovation ecosystem
Optimising cloud provisioning for pharmaceutical compliance and operational excellence
Suresh Perikala, Senior Engineering Lead - DevOps and Cloud Engineering Practice, Altimetrik
Accelerating pharma's sustainability efforts
Avinaw Prasad, Director, Climate Change & Sustainability, Deloitte India explains why integrating sustainability into the core pharma business strategy is essential for long-term success, analyses key focus areas and policy pushes which can incentivise companies to further evolve on the sustainability path
Drug Repurposing: Unlocking access to rare solutions
Drug repurposing, a quick, cost-effective path to deliver existing treatments to patients, can serve to expedite and expand healthcare access for patients with rare diseases
Optimising spend, maximising growth
Express Pharma, in partnership with IPA and CHEMEXCIL, powered by SAP, recently organised a thought leadership conclave on 'Reimagining spend management and supply chain' where cross functional experts explored strategies to drive value through supply chain transformation
